Krystal Biotech, Inc. KRYS 深 滬
等待開盤 09-09 09:30:00 美东时间
145.20
-5.070
-3.37%
華盛通- 最 高151.45
- 今 開150.21
- 成交量 32.16万股
- 最 低 142.915
- 昨 收 150.27
- 總市值 41.96亿
- 52周最高 207.84
- 市盈率 靜 48.43
- 換手率 0.00%
- 52周最低 122.80
- 委 比 88.69%
- 總股本 2889.87万
- 歷史最高 219.34
- 量 比 1.15
- 振 幅 5.68%
- 歷史最低 8.03
- 每 手 1
- 風險率 33.34%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Krystal Integrated Services Ltd. Expands with New Subsidiary in Port Services
Krystal Integrated Services Ltd. ( ($IN:KRYSTAL) ) has provided an announcement...
09-07 17:14
Krystal Biotech to Present at Cantor Global Healthcare Conference 2025
Krystal Biotech (NASDAQ: KRYS) announced its participation in the Cantor Global Healthcare Conference 2025 on September 4, 2025, in New York. Krish S. Krishnan, the Company’s Chairman and CEO, will engage in a fireside chat at 10:20 am ET and host investor meetings. A webcast of the presentation will be available starting at 10:20 am ET on September 4 and posted on the Investors section of the Company’s website. Krystal Biotech is a global biotec...
09-02 12:00
A Glimpse Into The Expert Outlook On Krystal Biotech Through 10 Analysts
10 analysts have shared their evaluations of Krystal Biotech (NASDAQ:KRYS) duri...
08-23 03:00
Krystal Biotech adjusts pipeline to prioritize inhaled antitumor agent
Krystal Biotech (NASDAQ:KRYS) announced Thursday a revamped product pipeline after a decision to prioritize studies for an inhaled version of its antitumor candidate KB707 targeted at non-small cell l...
08-22 00:59
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today
Krystal Biotech (NASDAQ:KRYS) has outperformed the market over the past 5 years...
08-18 22:15
美股大行评级 | 潜在涨幅345.51%！BTIG上调Syndax Pharmaceuticals目标价至56美元，维持"买入"评级
今日重点评级关注：BTIG：维持Syndax Pharmaceuticals"买入"评级，目标价从43美元升至56美元；花旗：维持Syndax Pharmaceuticals"买入"评级，目标价从46美元升至51美元
08-06 09:30
Citigroup Maintains Neutral on Krystal Biotech, Lowers Price Target to $166
Citigroup analyst Yigal Nochomovitz maintains Krystal Biotech (NASDAQ:KRYS) with a Neutral and lowers the price target from $176 to $166.
08-06 01:52
What 8 Analyst Ratings Have To Say About Krystal Biotech
In the preceding three months, 8 analysts have released ratings for Krystal Bio...
08-05 22:02
Krystal Biotech Q2 EPS $1.29 Beats $1.17 Estimate, Sales $96.042M Beat $94.254M Estimate
Krystal Biotech (NASDAQ:KRYS) reported quarterly earnings of $1.29 per share which beat the analyst consensus estimate of $1.17 by 10.35 percent. This is a 37.23 percent increase over earnings of $0.94 per share from the
08-04 19:01
Earnings Scheduled For August 4, 2025
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is likely to rep...
08-04 16:32
